BioStratum Could Receive $80M Per Antibody In Novo Cancer Deal Jan. 14, 2004 By Karen Carey No Comments
Acumen, Merck Sign Alzheimer's Disease Pact With $96M Potential Jan. 14, 2004 By Karen Carey No Comments
Concurrent Raises $15M, Partners With Intel On 'Machine Learning' Jan. 13, 2004 By Karen Carey No Comments
$19M Private Placement Ranks As Cortex's 'Biggest Financing' Jan. 12, 2004 By Karen Carey No Comments
Repligen's Secretin Fails Autism Phase III; Subgroup Has Promise Jan. 6, 2004 By Karen Carey No Comments The new year greeted Repligen Corp. with disappointing data from its Phase III trial of synthetic human secretin in autism. (BioWorld Today)Read More
ILEX Starts Clofarabine Filing Process, Begins Rolling NDA Oct. 23, 2003 By Karen Carey No Comments In a move to launch its second product in the U.S., ILEX Oncology Inc. filed the first part of a rolling new drug application on Wednesday for Clofarabine to treat refractory or relapsed acute leukemia in children.(BioWorld Today)Read More
